151 related articles for article (PubMed ID: 1393642)
1. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
Polívková J; Vosmiková K; Pospísil J; Poucková P
Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
[TBL] [Abstract][Full Text] [Related]
2. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
Polívková J; Vosmiková K; Horák L
Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
[TBL] [Abstract][Full Text] [Related]
3. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
Dwivedi C; Dixit M; Hardy RE
Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
López Sáez JJ; Senra-Varela A
Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
[TBL] [Abstract][Full Text] [Related]
6. Lipid-bound sialic acid as a tumor marker.
Dnistrian AM; Schwartz MK
Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
[TBL] [Abstract][Full Text] [Related]
7. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
Yue K; Bian M; Zhu D; Liu W; Siu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
[TBL] [Abstract][Full Text] [Related]
8. Lipid bound sialic acid in cancer patients.
Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
[TBL] [Abstract][Full Text] [Related]
9. The significance of serum lipid-bound sialic acid in bladder tumours.
Oztokatli A; Ozkardeş H; Ovül E; Erol D
Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
[TBL] [Abstract][Full Text] [Related]
10. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
Iwahashi N
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
[TBL] [Abstract][Full Text] [Related]
11. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
Zhu X
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
Patel PS; Baxi BR; Adhvaryu SG; Balar DB
Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of lipid bound sialic acid and acute phase proteins in patients with cancer and nonmalignant disease.
Raynes JG
Biomed Pharmacother; 1983; 37(3):136-8. PubMed ID: 6605767
[TBL] [Abstract][Full Text] [Related]
15. Changes of lipid-bound sialic acid in the plasma of mice bearing benzpyrene-induced tumors.
Polívková J; Vosmiková K; Pospísil J
Neoplasma; 1989; 36(6):667-71. PubMed ID: 2615870
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.
Dnistrian AM; Schwartz MK
Clin Chem; 1981 Oct; 27(10):1737-9. PubMed ID: 7285326
[TBL] [Abstract][Full Text] [Related]
17. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix.
Vivas I; Spagnuolo L; Palacios P
Gynecol Oncol; 1992 Aug; 46(2):157-62. PubMed ID: 1500016
[TBL] [Abstract][Full Text] [Related]
18. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
[TBL] [Abstract][Full Text] [Related]
19. Role of sialic acid and alkaline DNase in breast cancer.
Raval GN; Parekh LJ; Patel MM; Patel PS; Rawal RM; Balar DB; Patel DD
Int J Biol Markers; 1997; 12(2):61-7. PubMed ID: 9342634
[TBL] [Abstract][Full Text] [Related]
20. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
